Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
beclometasone + clotrimazole + lidocaine + neomycin
- Development stage
- Unknown
- Lead developer
- Sapient Laboratories
- Modality
- Small Molecules
- Administration
- Otic
01
Overview
OTOSAP-N is a combination ear drop formulation developed by Sapient Laboratories for the treatment of ear infections, including otitis externa and otitis media, accompanied by inflammation, pain, and itching. It is a fixed-dose combination containing four active ingredients: beclometasone dipropionate (a corticosteroid that reduces inflammation and swelling), clotrimazole (an imidazole antifungal that targets fungal cell membranes), lidocaine (a local anesthetic that blocks nerve pain signals), and neomycin (an aminoglycoside antibiotic that inhibits bacterial protein synthesis). This multi-action formulation provides comprehensive relief from mixed bacterial and fungal infections while managing associated discomfort.
- Brand names
- OTOSAP-N
- Other names
- beclometasone, clotrimazole, lidocaine and neomycinbeclomethasone + clotrimazole + lignocaine + neomycin
02
Targets
Bacterial RibosomeCYP51A1 (Sterol 14α-demethylase)GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on beclometasone + clotrimazole + lidocaine + neomycin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on beclometasone + clotrimazole + lidocaine + neomycin.